Literature DB >> 17325383

Abnormal prion protein in the pituitary in sporadic and variant Creutzfeldt-Jakob disease.

Alexander H Peden1, Diane L Ritchie1, Hafsana P Uddin1, Andrew F Dean2, Kimberley A F Schiller1, Mark W Head1, James W Ironside1.   

Abstract

By using high-sensitivity Western blotting and immunohistochemistry, pituitary glands from patients with sporadic and variant Creutzfeldt-Jakob disease (sCJD and vCJD, respectively) were analysed for the presence of the protease-resistant form of the prion protein (PrPres). PrPres was detected in a greater proportion of vCJD pituitaries than sCJD pituitaries and was localized predominantly in the neurohypophysis. PrPres was also detected in a recurrent pituitary adenoma from an sCJD patient. Immunohistochemical analysis showed sparse positive labelling, predominantly in folliculostellate cells, in vCJD and sCJD adenohypophyses. The PrPres glycosylation pattern in the vCJD neurohypophyses showed a predominance of the unglycosylated band, which differed markedly from patterns found in all other vCJD tissues. The presence of PrPres in the pituitary of CJD patients at autopsy suggests that human growth hormone-related iatrogenic CJD may have indeed resulted from infectivity in collected pituitaries rather than necessarily from contamination of pituitary pools by adjacent brain tissue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17325383     DOI: 10.1099/vir.0.81913-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone.

Authors:  David J Irwin; Joseph Y Abrams; Lawrence B Schonberger; Ellen Werber Leschek; James L Mills; Virginia M-Y Lee; John Q Trojanowski
Journal:  JAMA Neurol       Date:  2013-04       Impact factor: 18.302

2.  CSF pleocytosis and syndrome of inappropriate antidiuretic hormone secretion in Creutzfeldt-Jakob disease.

Authors:  Ali G Hamedani; Hannah C McLane; Grace Kimbaris; Dina A Jacobs; Joseph R Berger
Journal:  Neurol Clin Pract       Date:  2016-08

Review 3.  Sporadic and Infectious Human Prion Diseases.

Authors:  Robert G Will; James W Ironside
Journal:  Cold Spring Harb Perspect Med       Date:  2017-01-03       Impact factor: 6.915

4.  Transmission of chronic wasting disease identifies a prion strain causing cachexia and heart infection in hamsters.

Authors:  Richard A Bessen; Cameron J Robinson; Davis M Seelig; Christopher P Watschke; Diana Lowe; Harold Shearin; Scott Martinka; Alex M Babcock
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

5.  Amyloid-β accumulation in the CNS in human growth hormone recipients in the UK.

Authors:  Diane L Ritchie; Peter Adlard; Alexander H Peden; Suzanne Lowrie; Margaret Le Grice; Kimberley Burns; Rosemary J Jackson; Helen Yull; Michael J Keogh; Wei Wei; Patrick F Chinnery; Mark W Head; James W Ironside
Journal:  Acta Neuropathol       Date:  2017-03-27       Impact factor: 17.088

6.  Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States.

Authors:  Silvio Notari; Francisco J Moleres; Stephen B Hunter; Ermias D Belay; Lawrence B Schonberger; Ignazio Cali; Piero Parchi; Wun-Ju Shieh; Paul Brown; Sherif Zaki; Wen-Quan Zou; Pierluigi Gambetti
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

Review 7.  Molecular pathology of human prion diseases.

Authors:  Gabor G Kovacs; Herbert Budka
Journal:  Int J Mol Sci       Date:  2009-03-09       Impact factor: 5.923

Review 8.  Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Authors:  Gabor G Kovacs
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

9.  Commentary: Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.

Authors:  Isis Nem De Oliveira Souza; Evandro A De-Souza
Journal:  Front Aging Neurosci       Date:  2016-01-21       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.